Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

Product Availability Update

Promega Manufacturing and Delivery Systems continue to be fully operational during the COVID-19 outbreak. Our teams are in regular contact with suppliers and distributors worldwide and are taking all steps necessary to address both demands for diagnostic tools and reliable delivery of all products as quickly as possible. Learn more

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Combining On-Bead Conjugation and MS Analysis After IdeS Digestion Simplifies the Production and Characterization of ADCs

Part # PS222


Chris Hosfield1, Philip Compton2, Becky Godat1, Sergei Saveliev1, Archer Smith2, Nidhi Nath1, Paul Thomas2, Neil L. Kelleher2, Kevin Cook1, Michael Rosenblatt1 and Marjeta Urh1
1Promega Corporation, Madison, WI; 2Proteomics Center of Excellence, Northwestern University, Evanston, Il

Magnetic particles offer an efficient and scalable approach for conjugating small molecules to antibodies as demonstrated by conjugation of AlexaFluor to Rituximab.

Printed in USA.